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Abstract: Muscle carnosine has been reported to serve as a physiological buffer, possess 
antioxidant properties, influence enzyme regulation, and affect sarcoplasmic reticulum 
calcium regulation. Beta-alanine (β-ALA) is a non-essential amino acid. β-ALA 
supplementation (e.g., 2–6 grams/day) has been shown to increase carnosine 
concentrations in skeletal muscle by 20–80%. Several studies have reported that β-ALA 
supplementation can increase high-intensity intermittent exercise performance and/or 
training adaptations. Although the specific mechanism remains to be determined, the 
ergogenicity of β-ALA has been most commonly attributed to an increased muscle 
buffering capacity. More recently, researchers have investigated the effects of co-ingesting 
β-ALA with creatine monohydrate to determine whether there may be synergistic and/or 
additive benefits. This paper overviews the theoretical rationale and potential ergogenic 
value of β-ALA supplementation with or without creatine as well as provides future 
research recommendations.  
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1. Introduction 
 
During moderate to high-intensity exercise, hydrogen ions (H+) begin to accumulate leading to a 
drop in intramuscular pH and ultimately influencing muscle performance [1]. The greater the reliance 
on glycolysis as the primary energy system (as seen with high-intensity exercise), the greater 
production of lactic acid and H+, thus leading to further decreases in intramuscular pH. This decrease 
in intramuscular pH has been suggested to be linked to fatigue-induced increases in muscle activation 
and electromyographic (EMG) amplitude [2,3]. Thus, if the intramuscular pH decline can be prevented 
or delayed, the fatigue induced EMG increase may also be delayed [4]. Beta-alanine (β-ALA) 
supplementation has been shown to increase muscle carnosine levels, which can act as a buffer to 
reduce the acidity in the active muscles during high-intensity exercise [5-7]. β-ALA supplementation 
has been shown to have beneficial effects on exercise performance variables such as cycling  
capacity [6], ventilatory threshold, and time to exhaustion [8]. For this reason β-ALA has become a 
widely used nutritional supplement for improving high-intensity exercise performance [4-6,9,10]. 
Creatine monohydrate supplementation has also been shown to have ergogenic effects by increasing 
the availability of phosphocreatine (PCr), total creatine concentrations in the muscle, high intensity 
exercise performance, and training adaptations [11]. For this reason, several studies have assessed 
whether co-ingesting β-ALA with creatine may have synergist and/or additive effects on exercise 
capacity and/or training adaptations [4,10,12]. The purpose of this article is to review the theoretical 
rationale and available scientific evidence assessing the potential ergogenic value of supplementing the 
diet with β-ALA with or without creatine. In addition, to discuss areas that future research should 
address. This was accomplished by conducting a thorough review of the published literature related to 
the physiological effects of carnosine and the role of β-ALA and creatine supplementation on 
carnosine levels, creatine levels, and exercise performance.  
 
2. Carnosine 
 
Carnosine (β-alanyl-L-histidine) is a naturally-occurring histidine-containing compound found in 
many animal tissues, including skeletal muscle, which is the most abundant source. Carnosine is a 
multifunctional dipeptide with many roles including buffering [13,14], fighting free radicals [15,16], 
enzyme regulation [17] and sarcoplasmic reticulum calcium (Ca2+) regulation [18,19]. Carnosine is 
broken down in the body by carnosinase, which is found in most tissues except skeletal muscle, 
partially explaining why carnosine concentrations are highest in this tissue [19]. Figure 1 shows the 
chemical structure of carnosine.  
Carnosine in human skeletal muscle generally ranges between 5-10 mM wet weight or  
15–40 mmol/kg dry weight [5]. Concentrations differ among animal species, in part due to the 
differences in muscle mass [20]. For example, horses have been reported to have higher carnosine 
concentrations than greyhound dogs [21]. Carnosine levels are typically higher in fast-twitch muscle 
fibers compared to slow-twitch, which corresponds to the observation that animals exposed to frequent 
sprints, explosive flight behaviors and prolonged hypoxic dives have higher initial carnosine 
concentrations [5,21,22]. Human athletes involved in anaerobic sports such as sprinters [23,24] and 
bodybuilders [25] have also been found to have higher intramuscular concentrations of carnosine. 
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Exercise training has been reported to increase resting muscle carnosine concentrations in these athlete 
types. For example, Gardner and colleagues [26] reported that exercise training increased the plasma 
carnosinase activity and decreased carnosine excretion leading to greater muscle carnosine 
concentrations [26]. Moreover, Suzuki and colleagues [27] examined the effects of sprint training on 
muscle carnosine concentrations. Six male subjects performed sprint training twice a week for a total 
of 16 training sessions. Each session involved either single (for weeks one and two) or a double (for 
weeks three through eight) bout of 30 seconds of maximal sprinting on a cycle ergometer with 20 
minutes of rest between sprints on the double bout days. Muscle samples were collected from the 
vastus lateralis one week before training and again two days following the training protocol. Results 
revealed that muscle carnosine content and mean power output significantly increased after the eight 
weeks of training [27]. Tallon and coworkers [25] suggested the greater muscle carnosine content in 
bodybuilders may be due to the chronic exposure to lower pH environments due to their training, 
differences in their diet such as increased protein intake where carnosine can be found, 
supplementation use, and/or possible anabolic androgenic steroid use [25]. 
Figure 1. Chemical structure of carnosine. 
 
 
Carnosine was first discovered as an intracellular pH buffer in 1953 by Severin and colleagues [28] 
using frog muscle tissue. Subsequent studies examining this relationship in human muscle tissue 
followed thereafter [13,14,29-32]. When skeletal muscles are involved in moderate to intense exercise, 
there is typically a generation of lactic acid and subsequent dissociation into lactate and H+, which can 
alter the pH levels. It had previously been reported that the majority of protons produced during 
exercise in the blood were buffered by the bicarbonate buffering system [33]. The pKa of this system 
is 6.1, which is less than that of carnosine (pKa of 6.83), and thus a greater pH change is needed to 
elicit benefits from this system. Since the pKa of carnosine is closer to the physiological pH, it is likely 
that this is utilized sooner as a buffer during high-intensity exercise [1]. The imidazole group on the 
histidine containing molecules, such as carnosine, makes it especially effective as a buffer. This group 
has a pKa value close to that of the intracellular pH, therefore one of the nitrogens from the imidazole 
ring can be used to accept a proton [34].  
Early studies examined the role of carnosine in animal models. One study, utilizing chromatography 
methodology to analyze rabbit and pigeon muscle samples, reported muscle dipeptides (mainly 
carnosine and anserine) accounted for approximately 40% of the pH buffering capability in skeletal 
muscle [13]. Later, Bump and colleagues [35] examined the carnosine concentrations in different 
breeds of horses. They compared quarter horses (QH), thoroughbreds (TB) and standardbreds (SB) in 
order to correlate buffering capabilities of the muscle to fiber type composition. The QH demonstrated 
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less slow-twitch muscle fibers, greater fast-twitch glycolytic fibers, and fewer fast-twitch oxidative 
muscle fibers compared to the other horses. Results showed QH had significantly greater amounts of 
carnosine in their muscle. The researchers reported a positive correlation between carnosine 
concentrations and fast-twitch glycolytic fibers and a negative correlation between carnosine and fast-
twitch oxidative fibers. The investigators inferred that intramuscular carnosine acted as an intracellular 
buffer, although this was not directly measured. A later study conducted by Sewell and associates [36] 
specifically examined the buffering capability of carnosine in different fiber types of horses. These 
researchers found that carnosine contributed about 20% of the buffering in type I fibers and up to 46% 
in Type IIb fibers. These findings are consistent with the findings that less lactic acid is accumulated in 
Type I fibers due to the lower intensity muscle activity involved with this fiber type.  
An early study by Kraemer and associates of humans utilizing carnosine supplementation [37] 
reported no effect on the acid-base status or exercise performance using four subsequent 30 second 
Wingate tests with only two minutes of rest between exercise bouts. In this regard, the researchers 
evaluated ten trained and ten untrained males who consumed a total of 15 capsules of a supplement 
containing 1000 mg dibasic sodium phosphate, 204 mg potassium bicarbonate and 12.5 mg L-
carnosine over a 3.5 day period. Placebo capsules were matched in sodium and potassium content. 
Blood samples were taken at baseline prior to any exercise, immediately after each Wingate test, and at 
three minutes after all exercise was completed. Though intramuscular carnosine levels were not 
measured, the authors suggested that the amount of carnosine provided to subjects (about 185 mg) may 
have been too low to have an impact on intramuscular carnosine levels [26,38,39] particularly since 
previous animal studies had shown increases following a daily dose between 50-200 mg/kg of body 
weight [38,40].  
Human studies have shown that lowered pH levels can also negatively affect the excitation-
contraction coupling in the skeletal muscle [38,41]. The buffer efficacy in human muscle was 
examined by calculating the buffering ability over the physiological pH range of 7.1–6.5. This study 
involved 50 healthy active individuals who underwent a muscle biopsy from the lateral portion of the 
quadriceps femoris muscle. Anserine and carnosine were analyzed in neutralized perchloric acid 
extracts using high performance liquid chromatography (HPLC) methods. The Henderson-Hasselbach 
equation was then used to indirectly calculate the buffer contribution across the pH range of 7.1 to 6.5. 
It was estimated that carnosine was able to buffer between 2.4 and 10.1 mmol H+·kg-1 dry mass, which 
corresponded to about 7% of the total muscle buffering [9]. Therefore, these results indicated that 
carnosine played a minimal role in buffering pH.  
Suzuki and coworkers [42] examined the effects of the non-bicarbonate buffers carnosine and 
anserine. They had eight active males supplement with either a placebo or chicken breast extract 
(CBEX) soup that contained 1.5 g carnosine and anserine. Subjects then performed ten sets of five 
second maximal cycle sprints at 7.5% of their body weight as resistance. Blood samples were collected 
at rest, one minute before exercise, after each exercise set, and immediately after the intervals to 
measure blood-gas parameters, blood lactate and concentrations of carnosine and anserine. The 
researchers found that supplementing the diet with CBEX delayed the decrease in bicarbonate during 
intense exercise, but did not improve performance. These results support the initial use of carnosine as 
a buffer instead of the bicarbonate system [42].  
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Early studies with carnosine supplementation noted plasma carnosine levels failed to elevate due to 
the high activity of carnosinase [26]. The researchers were able to measure only 14% of the ingested 
carnosine in urine suggesting this was due to absorption in the gastrointestinal tract [26]. Later, 
research pointed towards supplementing with β-ALA and L-histidine instead to raise carnosine levels 
since these are the precursors to carnosine. Dunnett and Harris [14] discovered that β-ALA was able to 
increase carnosine in muscle tissue. In their study, they supplemented horses with both β-ALA and L-
histidine and found β-ALA to have an additive response suggested to be due to the increase β-amino 
acid transport across the gastrointestinal tract. This was not observed for L-histidine, thus speaking to 
the efficacy of β-ALA instead to increase carnosine levels [14]. However, Tamaki and coworkers [43] 
were able to show an increase in carnosine with histidine in rats [43].  
Aside from the buffering effects, carnosine has shown to have other physiological roles, including 
that of an effective antioxidant against oxidative stress [44]. Reactive oxygen species (ROS) can arise 
from exercise in several proposed mechanisms including: an increase flow of electrons in the electron 
transport system from increased respiration [45] or a decrease in pH can lead to oxygen being released 
from hemoglobin and a subsequent increase in pO2 in the tissues [46]. Some believe the development 
of ROS to be related to muscle fatigue during activity [47,48].  
Carnosine is also linked to enzyme regulation related to activation of myosin ATPase, which is used 
to help maintain ATP stores [49]. Finally, carnosine has been noted to have a role in electron-
contraction (E-C) coupling in skeletal muscle. An early study by Lamont and Miller [50] showed 15 
mM of carnosine resulted in a significant increase in Ca2+ sensitivity in muscle fibers of Rana 
temporaria [50]. More recently, Dutka and Lamb [51] examined if carnosine affects E-C coupling in 
functional fibers under physiological conditions. They used mechanically skinned rat extensor 
digitorum longus muscle fibers. Their results showed that carnosine did not affect Ca2+ release from 
the sarcoplasmic reticulum; however, carnosine was able to increase the Ca2+ sensitivity of the 
contractile components of the muscle fibers. Authors suggested the assistance in Ca2+ sensitivity could 
help maintain force production in the later stages of fatigue once Ca2+ release begins to decrease. 
Therefore, higher levels of carnosine can help offset the decrease in Ca2+ as well as the accumulation 
of H+ ions during high-intensity exercise [51]. 
Since carnosine has a number of physiological roles, there are a number of future research 
opportunities. Specifically, the exact mechanism of carnosine in its role to improve exercise 
performance and/or reduce muscular fatigue needs to be studied. It will also be important to examine 
how different nutritional strategies to increase carnosine levels in the muscle may optimize 
physiological activity and/or exercise capacity.  
 
3. Beta-Alanine 
 
β-ALA is a naturally occurring amino acid that is one of the precursors to carnosine, along with L-
histidine. Carnosine synthetase is the enzyme used to synthesize carnosine from β-ALA and L-
histidine. β-ALA is also likely to be the rate-limiting step in the synthesis of carnosine [14,52,53]. 
Carnosinase is the enzyme present in cells and serum that breaks down carnosine into β-ALA and  
L-histidine [54]. 
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β-ALA supplementation in doses greater than 10 mg/kg of body weight has shown to cause a short 
period of paraesthesia with increasing severity as the dose increases. However, when a large dose 
around 40 mg/kg of body weight is ingested with CBEX, the paraesthesia did not occur. It is 
hypothesized that this side effect is a result of the rapid high peak blood plasma concentrations of β-
ALA with supplementation alone, since it is not experienced when β-ALA is ingested through the diet 
with histidine containing dipeptides such as carnosine in meat products [7]. 
 
3.1. Beta-Alanine and Carnosine 
 
As previously mentioned, β-ALA supplementation has recently been shown to significantly increase 
intramuscular carnosine levels, which then corresponds to improvements in exercise performance [8]. 
Harris and colleagues [7] examined the effects of β-ALA supplementation on human skeletal muscle 
carnosine concentration in a series of studies. In one study, investigators examined the effects of four 
weeks of β-ALA or carnosine supplementation on muscle carnosine concentrations. The 
supplementation protocol included consuming 800 mg of β-ALA four times a day (i.e., 2.3 g/day) for a 
total intake of approximately 90 g over the four week period (group I) or increasing doses of β-ALA 
through the supplementation period (average 6.4 g/day) for a total intake of about 146 g over the four 
week period (group II). The carnosine supplementation group involved consuming increasing doses of 
L-carnosine through the supplementation period for a total intake of 364 g of L-carnosine over the four 
week period which corresponded to an intake of about 143 g of β-ALA. A final group supplemented 
with maltodextrin as a placebo in the same frequency as the β-ALA and L-carnosine supplementation 
groups. A muscle biopsy was taken before and after supplementation. Results revealed that each 
supplement group showed significant increases in carnosine content. Mean carnosine content increase 
(measured in mmol·kg-1dm) was greatest with L-carnosine and was followed by groups II and I of β-
ALA with values of 16.37 ± 3.03 (p < 0.05), 11.04 ± 2.68 (p < 0.05) and 7.80 ± 0.36 (p < 0.05) 
mmol·kg-1dm, respectively. There was no change in the placebo group (1.87 ± 1.73, p>0.05 mmol·kg-
1dm). This corresponded to percent changes of 66%, 64%, 42%, and 10% for L-carnosine, group II, 
group I and placebo group, respectively. They also indirectly calculated the contribution of carnosine 
to buffering capacity between pH levels of 7.1 and 6.5 using the Henderson-Hasselbach equation. They 
found that after four weeks of supplementation, carnosine accounted for about 14.2%, 14.3%, and 
12.6% of the total muscle buffering capacity in the L-carnosine group, group II, and group I, 
respectively [7]. 
Studies have also suggested that there does not appear to be an upper limit on increasing muscle 
carnosine concentrations. For example, Derave and colleagues [5] supplemented trained male sprinters 
with β-ALA or placebo (maltodextrin) for four to five weeks. The supplementation protocol included 
six daily doses of 400 mg capsules of either β-ALA or maltodextrin totaling 2.4 g/day for the first four 
days, 3.6 g/day for the next four days, and 4.8 g/day for the duration of the study. Interestingly, muscle 
carnosine levels were increased even in individuals with high resting muscle carnosine  
concentrations [5].  
While β-ALA and carnosine supplementation have been reported to increase muscle carnosine 
levels, less is known about the time course of carnosine degradation. Carnosinase is responsible for the 
hydrolyzation of carnosine and is mainly present in human plasma, which is why carnosine levels are 
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much lower in the blood than in skeletal muscle, where this enzyme is not present [26]. β-ALA 
supplementation in doses of 4-6 g/day over time has been shown to increase carnosine by 20-30% after 
two weeks, by 40-60% after four weeks, and up to 80% by ten weeks [6,55]. A study by Baguet and 
colleagues [56] sought to determine the loading phase of carnosine and the time course of removal. 
They included 20 males who supplemented with either β-ALA or maltodextrin as a placebo for five to 
six weeks. The investigators provided doses of 2.4 g/day for days one and two, 3.6 g/day for days three 
and four, and 4.8 g/day for the remainder of the study duration. Using a proton magnetic resonance 
spectroscopy (MRS), they measured the carnosine content in three different muscles (soleus, tibialis 
anterior, and gastrocnemius) at four time points (pre-supplementation, during the last week of 
supplementation and at weeks three and nine following the cessation of supplementation). They 
determined that carnosine elimination occurs relatively slowly and in a linear pattern at an average rate 
of 0.21 mM/week in both type I and II fibers. Authors suggest the slow clearance of carnosine is 
indicative of the high stability of the metabolite [56]. Table 1 provides a summary of recent studies 
examining the effects of β-ALA supplementation on carnosine concentrations.  
Table 1. Summary of the effects of β-ALA supplementation on muscle carnosine concentrations. 
Authors Population Supplementation Protocol Muscle Carnosine 
Concentration Effects 
Performance 
Results 
Baguet et al., 
2009 [56] 
20 physically 
active males 
5-6 weeks of β-ALA or 
placebo (maltodextrin) 
2.4 g/day – first 2 days 
3.6 g/day – days 3-4 
4.8 g/day to end of study 
 
 
• In soleus, carnosine increased 
30% (p=0.003) with β-ALA 
and remained stable with 
placebo (p=0.867) 
• In tibialis anterior, carnosine 
increased 27% (p=0.005) with 
β-ALA and decreased 17% 
(p=0.05) with placebo 
• In gastrocnemius, carnosine 
increased 23% (p=0.038) and 
did not change with placebo 
(p=0.740). 
• Carnosine elimination was 
measured at 3 and 9 weeks 
after supplementation period 
• At 3 weeks, only 26.1% (in the 
soleus), 20.1% (in tibialis 
anterior) and 44.7% (in the 
gastrocnemius) of the increase 
had disappeared. There was 
no difference between β-ALA 
and placebo at this point 
(p=0.431) 
• At 9 weeks, carnosine levels in 
all 3 muscles returned to 
initial values 
• None 
measured  
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Table 1. Cont. 
Harris et al., 
2006 [7] 
Study 3: 
21 physically 
active males 
Ages 26.1 ± 5.6 
yrs 
 4 weeks, 4 groups (I – IV): 
 I) 800mg β-ALA x 4  
 daily (avg. 3.2g daily  
 and 89.6g 4wk total) 
II) 8 daily doses of  
 either 400 or 800mg  
 β-ALA (avg. 6.4g  
 daily and 145.6g 4wk  
 total) 
III) 8 daily doses of  
 1000 or 2000 mg L- 
 carnosine (364g 4wk  
 total L-carnosine,  
 corresponding to  
 143.3g β-ALA) 
IV) Placebo of  
 maltodextrin at  
 doses to match  
 groups II and III 
 
• Increase in carnosine 
concentration greatest with 
carnosine supplementation, 
followed by group II, then 
group II β-ALA protocols.  
• Mean increase over 4 weeks 
(mmol·kg-1dm) 
 I) 7.80 ± .36 (p < .05) 
 II) 11.04 ± 2.68 (p < .05) 
 III) 16.37 ± 3.03 (p < .05) 
 IV) 1.87 ± 1.73 (p>.05) 
None measured 
Derave et al., 
2007 [5] 
15 male track 
athletes 
(sprinters) 18-24 
yrs 
4-5 weeks β-ALA or 
placebo (maltodextrin) 
2.4g/day – first 4 days 
3.6g/day – days 5-8 
4.8g/day to end of study 
 
Soleus: 
•  ↑ 47% with β-ALA  
•  No change with placebo 
Gastrocnemius: 
•  ↑ 37% with β-ALA 
•  No change with placebo 
 
No difference 
between groups 
for 400m running 
performance 
Hill et al., 
2007 [6] 
25 physically 
active males 
10 weeks 
β-ALA: 
4g/day – wk 1 
4.8g/day – wk 2 
5.6g/day – wk 3 
6.4g/day – wk 4-10 
• β-ALA group, ↑ from 19.0 to 
30.1 mmol/kg (58.8%) at 4 
weeks and up to 34.7 
mmol/kg (80.1%) at 10 weeks 
• Not significant between weeks 
4 and 10 
• No effect on 
body mass 
• ↑cycling 
capacity time 
at 110% with 
β-ALA 
 
3.2. Beta-Alanine and Exercise Performance 
 
Increases in muscle carnosine due to β-ALA supplementation have resulted in significant effects on 
several variables related to exercise performance. Some of these include improved time to fatigue on a 
maximal cycle test [6], increased ability to sustain power output in the final ten seconds of the Wingate 
test [31], delayed onset of neuromuscular fatigue during incremental cycle ergometry tests as noted by 
increased physical working capacity (PWCFT), increased ventilatory threshold (VT) and time to 
exhaustion (TTE) [8], and improvements in muscle torque during repeated bouts of intense dynamic 
contractions [5]. 
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Since studies have reported that muscle carnosine levels are typically higher in fast-twitch muscle 
fibers, which are most predominantly used in high-intensity anaerobic exercise bouts, it has been 
hypothesized that β-ALA supplementation could aid in anaerobic performance. In 2002, Suzuki and 
colleagues [31] performed a study that did not involve any nutritional supplementation, but simply 
analyzed muscle biopsy samples from the vastus lateralis before and after a 30-second maximal cycle 
sprint Wingate test. The muscle samples were analyzed for carnosine content. Analysis showed a 
direct relationship between carnosine concentration in skeletal muscle and performance on the 30-
second Wingate exercise test. This relationship lends itself to the question of efficacy of β-ALA 
supplementation in further improving anaerobic exercise performance.  
Hill and coworkers [6] examined the effects of four and ten weeks of β-ALA supplementation on 
muscle carnosine concentration and high-intensity cycling capacity. They also sought to discover 
whether the effects were muscle type specific. Physically active males supplemented with either β-
ALA or maltodextrin as a placebo. β-ALA was given in eight doses per day with increasing dose 
amounts during the first four weeks ranging from 250-750 mg per dose. Subjects underwent muscle 
biopsies and maximal cycle performance tests at various points during the study. The group 
supplementing with β-ALA had significantly greater muscle carnosine concentrations at four and ten 
weeks from 19.9 ± 1.9 to 30.1 ± 2.3 (30.4%) and 34.7 ± 3.7 (35.1%) mmol·kg-1dm. There was no 
significant change with placebo. The change between four and ten weeks with β-ALA was not 
significant despite the small increase (p~0.07). The results also indicated no difference between fiber 
types, in that each showed similar increases in carnosine as measured by HPLC with fluorescence 
detection. The authors suggested that the possible benefits from β-ALA supplementation may be 
limited to four weeks, which is in agreement with previous findings by Suzuki and coworkers [31] who 
showed an increase in the ability to sustain power output after four weeks of supplementation with no 
additional benefits observed at ten weeks [31].  
Limited research has examined the effects of β-ALA on sport-specific anaerobic performances. 
Derave and colleagues [5] studied the effects of a four week supplementation period on athletic 
performance, using a 400 m running race time trial. The researchers found no significant differences in 
performance after supplementation, but suggested this may have been due to the short time period of 
supplementation since it takes several weeks to induce carnosine loading. Using a proton MRS to 
detect muscle carnosine concentrations, investigators showed an increase in carnosine concentrations 
of 47% in the soleus muscle after β-ALA supplementation with no significant increase after placebo 
supplementation (8%). Both groups showed significant increases in carnosine concentrations in the 
gastrocnemius but subjects supplementing their diet with β-ALA observed a greater increase (37% 
versus 16%) [5]. This is in contrast to the previously discussed study that reported performance 
improvements after four weeks of supplementation [6]. The researchers suggested that this may be due 
to the possibility that in trained athletes, a 400 m running performance is not necessarily limited by the 
intracellular pH decrease, and therefore the buffering capabilities of the increased carnosine 
concentrations would not be as critical of a component [5].  
Another recent study sought to determine whether β-ALA supplementation would affect endurance 
cycling performance. Van Thienen and colleagues [57] evaluated whether β-ALA supplementation 
would enhance the final sprint performance during endurance cycling since many competitions are 
won in the final seconds of the race after an all-out sprint. They studied 21 trained males who 
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supplemented their diet with either β-ALA or a maltodextrin placebo for eight weeks. The dose 
gradually increased from 2 g/day for the first two weeks, 3 g/day for weeks three and four, to 4 g/day 
for weeks five to eight. The exercise test involved 110 minutes of cycling in ten minute stages with 
increasing intensity between 50–90%. Following this, the subjects performed a 30 second all-out 
sprint. The researchers reported that β-ALA supplementation increased sprint peak power after a two 
hour endurance exercise bout by 11–15% (p=0.0001) and mean power output by 5–8%  
(p = 0.005) [57]. 
In contrast to trained individuals, Smith and colleagues [58] recently examined the combined effects 
of six weeks of β-ALA supplementation and high-intensity interval training on endurance performance 
in recreationally active males. In this study, 46 participants were randomly assigned to either β-ALA 
or placebo supplementation groups. Both groups trained at 90–110% of their peak oxygen utilization 
(VO2peak) for the first three weeks, followed by three weeks of training at 115% VO2peak. During the 
training, they continually supplemented with 6 g/day of β-ALA or a dextrose placebo for the first three 
weeks and 3 g/day for the second three weeks. They showed increases in both groups for VO2peak, 
time to reach VO2peak, and total work done. However, the group ingesting β-ALA observed a greater 
increase in VO2peak and time to reach VO2peak during the second three weeks of the training protocol 
(p < 0.05), with no change in the placebo group. They also noted a significant increase in lean body 
mass for the β-ALA group after the first three weeks. These results suggest that β-ALA 
supplementation may enhance the effects of high-intensity interval training and improve endurance 
performance in untrained individuals. Additionally, Smith and colleagues [59] examined the effects of 
the same high-intensity interval training and β-ALA supplementation protocol described above on 
neuromuscular fatigue and function. The researchers reported that three weeks of the interval training 
was sufficient to result in a significant increase in the EMG fatigue threshold (EMGFT). However, β-
ALA supplementation did not promote greater benefits [59]. Table 2 presents a summary of recent 
studies examining the effect of β-ALA supplementation and carnosine loading on  
exercise performance.  
Table 2. Summary of recent β-ALA supplementation and exercise performance studies. 
Authors Population Supplementation 
Protocol 
Exercise Testing 
Protocol 
Performance Results 
Baguet et 
al., 2009 
[60] 
14 physically 
active males 
4 weeks of β-ALA or 
placebo 
(maltodextrin) 
2.4 g/day – first 2 
days 
3.6 g/day – days 3-4 
4.8 g/day to end of 
study 
 
Maximal ramp exercise 
test on cycle ergometer 
to determine VO2peak, 
VT and gas exchange 
threshold 
 
Pre and Post 
supplementation: 3 x 
6min cycle exercise 
bouts at 50% ∆ power 
output 
• Exercise-induced acidosis was 
19% lower with β-ALA  
• No difference in VO2 throughout 
exercise before or after 
supplementation in either group 
• Time delay in the fast component 
was significantly shorter with β-
ALA than placebo 
• Does not support a role for 
acidosis in O2 deficit or the slow 
component of VO2 kinetics 
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Table 2. Cont. 
Stout et al., 
2006 [4] 
51 males 4 groups: 
• Placebo – 34 g 
dextrose 
• Creatine – 5.25 g 
creatine monohydrate 
and 34 g dextrose 
• β-ALA – 1.6 g β-ALA 
plus 34 g dextrose 
• β-ALA+Creatine – 
5.35 g creatine 
monohydrate, 1.6 g β-
ALA and 34 g 
dextrose 
28 days of 
supplementation: 
• 4 doses/day - days 1-6 
• 2 doses/day - days 7-
28 
 
PWCFT test with EMG 
measurements on a cycle 
ergometer 
• β-ALA may delay the onset 
of neuromuscular fatigue, 
but no additive effects of 
creatine 
• Significant increase in 
PWCFT with β-ALA 
(14.5%) and creatine plus β-
ALA (11%) compared to 
placebo 
Stout et al., 
2007 [8] 
22 females 
Ages: 
28.9 ± 8.1 
yrs (β-ALA) 
25.8 ± 4.0 
yrs (placebo) 
• 4 weeks β-ALA or 
placebo 
• 4 divided doses/day for 
totals of: 
• 3.2g/day – days 1-7 
• 6.4g/day – days 8-28 
 
Continuous graded 
exercise test on cycle 
ergometer for VO2max, 
ventilatory threshold , 
PWCFT and TTE  
β-ALA delays onset of NMF 
during incremental cycle 
ergometry (↑ PWCFT, ↑VT, 
↑TTE) 
Stout et al., 
2008 [61] 
26 elderly 
males and 
females 
90 days supplementation 
with β-ALA or placebo 
(microcrystalline 
cellulose) 
3 doses/day of: 
2.4 g β-ALA or 
2.4 g placebo 
 
Continuous graded 
exercise test on cycle 
ergometer for PWCFT 
with EMG measurements  
• 28,5% increase in PWCFT 
after 90 days of β-ALA 
Sweeney et 
al., 2009 
[62] 
19 physically 
active 
college-aged 
males  
5 weeks β-ALA or placebo 
(rice flour) 
• 4g/day – week 1 
• 6g/day – weeks 2-5 
2 sets of 5x5-sec sprints 
with 45- sec recovery 
between sprints and 2 
min between sets 
performed on non-
motorized treadmill at 
15% body weight as 
resistance  
• No between group 
difference for peak or mean 
horizontal power 
• No difference in % fatigue 
• No difference in blood 
lactate pre- and post-testing 
between groups 
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Table 2. Cont. 
Van Thienen 
et al., 2009 
[57]  
17 healthy 
young males 
8 weeks β-ALA or 
placebo (maltodextrin) 
• 2 g/day – weeks 1-2 
• 3 g/day – weeks 3-4 
• 4 g/day – weeks 5-8 
Simulated road race of 
110 minutes intermittent 
endurance with intensity 
between 50% and 90% of 
the maximal lactate 
steady state (MLSS) in 10 
minute stages. 
Immediately after this, 
they started a 10 minute 
time trial at 100% MLSS 
with voluntary increase of 
intensity at each minute. 
 
• β-ALA enhanced sprint 
power output at the end of 
the endurance race 
compared to placebo 
Zoeller et 
al., 2007 
[10] 
55 males 
ages 24.5 ± 
5.3 yrs 
4 weeks, 4 groups (4 
doses/day for first 6 days, 
then 2 doses/day 
• Placebo – 34g dextrose 
• Creatine – 5.25g 
creatine monohydrate 
and 34g dextrose 
• β-ALA – 1.6g β-alanine 
and 34g dextrose 
• β-ALA plus Creatine – 
5.25g creatine 
monohydrate, 1.6g β-
ALA and 34g dextrose 
 
Continuous graded 
exercise test on cycle 
ergometer  
• ↑ in 5 cardio-respiratory 
endurance variables with 
creatine + β-ALA 
• Combined supplementation 
may delay the onset of VT 
and lactate threshold during 
incremental cycle exercise 
 
3.3. Beta-Alanine and Exercise Training 
 
Many athletes incorporate resistance exercise as part of their training. Resistance-exercise has been 
reported to lower pH levels to around 6.8 during an exercise session [63,64]. Thus, β-ALA 
supplementation may provide ergogenic value to athletes engaged in resistance training due to the 
heavy reliance on glycolytic systems in the exercises [9]. Several recent studies have examined this 
hypothesis. For example, Kendrick and coworkers [9] examined the effects of ten weeks of resistance 
training with and without β-ALA supplementation on muscle carnosine concentration and performance 
measures. Subjects consumed 6.4 g/day of β-ALA or a maltodextrin placebo for ten weeks. Results 
revealed that β-ALA supplementation increased muscle carnosine levels by 12.8 ± 8 mmol/kg dry 
muscle weight in with previous research [6,7]. However, the researchers reported that β-ALA 
supplementation had no effects on whole body strength, isokinetic force production, muscular 
endurance, or body composition [9].  
In a follow-up study, Kendrick and colleagues [65] performed a study examining the effects of four 
weeks of β-ALA supplementation on isokinetic training adaptations and muscle carnosine content in 
type I and II fibers. Fourteen male subjects were divided into two supplementation groups. Subjects 
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ingested 800 mg of β-ALA or a maltodextrin placebo eight times per day for four weeks (6.4 g/day). 
Subjects trained three times a week for the first two weeks and four times a week for weeks three and 
four. Each session consisted of ten sets of ten maximal 90° knee extension and flexion contractions at 
180°/sec on the right leg using a Kin-Com isokinetic dynamometer with one minute of rest between 
sets. The left leg acted as the untrained control. Muscle biopsies were obtained from the trained and 
untrained legs prior to and following the training and supplementation period. Results revealed that 
carnosine content was increased in the trained (9.6 ± 3.9 mmol/kg dry muscle) and untrained legs  
(6.6 ± 2.4 mmol/kg dry muscle) with no significant differences observed between groups. In addition, 
no significant differences were observed between carnosine concentrations in type I and type II fiber 
types. The researchers concluded that four weeks of isokinetic training is not effective in increasing 
carnosine content and that β-ALA supplementation serves to increase muscle carnosine concentration 
in both untrained and trained type I and type II muscle fibers [65]. Other recent studies support 
contentions that β-ALA supplementation can enhance training adaptations [12,58,59]. Table 3 provides 
a summary of recent studies on β-ALA supplementation and exercise training.  
Table 3. Summary of recent β-ALA supplementation and exercise training studies. 
Authors Population Supplementation 
Protocol 
Exercise Protocol Muscle Carnosine 
Concentration Effects 
Performance 
Results 
Hoffman 
et al., 2006 
[12] 
33 male 
strength 
power 
athletes 
• 10 weeks 
• Creatine β-
ALA (CA) – 
10.5g/day 
creatine 
monohydrate 
and 3.2g/day β-
ALA 
• Creatine (C) – 
10.5g/day 
• Placebo (P) – 
10.5g/day 
dextrose 
Resistance training program 
4 days/week for 10 weeks 
Not measured • ↓ fatigue rate 
in CA 
• ↑ ∆ lean 
body mass 
and % body 
fat 
• No change in 
power 
measures 
• ↑ training 
volume in 
CA 
Kendrick 
et al., 2008 
[9] 
26 healthy 
males, 19-
24 yrs 
800mg x 8/day 
for 4 weeks of β-
ALA or placebo 
(maltodextrin) 
Resistance training 
4days/wk for 10 weeks 
• β-ALA – 23.96 ± 
5.94 to 36.77 ± 8.26 
(p < 0.0001) 
• Placebo – 29.17 ± 
9.82 to 27.29 ± 9.52 
(p > 0.05) 
No difference in 
whole body 
strength or 
isokinetic force 
 
Kendrick 
et al., 2009 
[65] 
14 
Vietnamese 
college 
aged 
students 
4 weeks β-ALA 
or placebo 
(maltodextrin) 
800mg x 8/day 
Single legged isokinetic 
training  
3 sessions – weeks 1-2 
4 sessions – weeks 3-4 
10 × 10 maximal 90° 
extension and flexion 
contractions at 180°/sec on 
Kin-Com 
• Carnosine ↑ in both 
trained and untrained 
legs with β-ALA 
• Training alone had 
no effect on 
carnosine levels 
None measured.  
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Smith et 
al., 2009 
[59] 
46 
recreational
ly active 
young 
males 
6g/day for 3 
weeks, then 
3g/day for 2nd 3 
weeks of β-ALA 
or placebo 
(dextrose) 
High intensity interval 
training 
Not measured Training 
increased 
EMGFT, no 
additive effect 
with β-ALA 
Smith et 
al., 2009 
[58] 
46 
recreational
ly active 
young 
males 
6g/day for 3 
weeks, then 
3g/day for 2nd 3 
weeks of β-ALA 
or placebo 
(dextrose) 
High intensity interval 
training 
Not measured • ↑ VO2peak 
and time to 
reach 
VO2peak 
with β-ALA 
• ↑ lean body 
mass with β-
ALA 
 
3.4. Beta-Alanine and Muscular Fatigue 
 
There are several factors that play a role in muscular fatigue with high-intensity exercise. Some 
common theories include a disruption of the neuromuscular junction; a decrease in Ca2+ release and 
uptake leading to the inability of muscles to contract; a depletion of fuel stores such as ATP; 
production of free radicals due to oxidative stress; and, the accumulation of metabolites such as  
H+ [38]. Carnosine has been implicated to play a role in each of these proposed mechanisms of fatigue, 
but is most commonly researched for its effect on metabolite accumulation as a buffer.  
The previously mentioned study by Derave et al. [5] also examined the effects of β-ALA 
supplementation on isokinetic and isometric fatigue. The isokinetic protocol involved performing five 
sets of 30 maximal voluntary isokinetic knee extensions at 180°/sec with one minute of recovery 
between sets on the right leg. The isometric protocol was performed on the left leg and involved a 
maximal static voluntary contraction (MVC) at 45°. Once the MVC was determined, subjects 
performed isometric contractions at 45% of the MVC for as long as possible. Results indicated that 
carnosine loading significantly improved the latter stages of exercise (sets four and five of the 
isokinetic test). The researchers noted that the observed response with β-ALA supplementation had 
similar results as muscle creatine loading on muscle fatigue [66]. The authors also suggested the 
increase in carnosine attenuated fatigue by not only its buffering capacities, but also by its ability to 
improve myofibrilar Ca2+ sensitivity.  
Neuromuscular fatigue is defined as an increase in electrical activity of a working muscle over  
time [67,68,69]. The increase in electrical activity is observed by the increase in EMG amplitude and is 
indicative of the recruitment of more motor units and/or the increase in firing rate of the active motor 
units in order to attempt and sustain the given activity [69]. The accumulation of H+ ions is one 
possible explanation for this EMG response. Other possible explanations include depleted energy 
stores and impaired regulation of muscle cations [2,70]. deVries and coworkers [67] developed a 
protocol to assess neuromuscular fatigue threshold. It was termed the PWCFT and examines the 
relationship between EMG amplitude and fatigue during cycle ergometry. This specifically measures 
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the power output at the point of neuromuscular fatigue [8]. Subsequent studies have shown 
relationships between PWCFT and VT as well [69,71].  
Since it has been established in previous research that β-ALA supplementation has enhanced 
buffering capabilities during exercise by the subsequent increase in muscle carnosine  
content [5,6,7,9,31], it has been hypothesized that β-ALA supplementation may delay fatigue [8]. Until 
recently, this had only been shown in trained and untrained men [7]. Stout and coworkers [8] examined 
the effects of 28 days of β-ALA supplementation in women on PWCFT, VT, VO2max, and TTE during 
a cycle ergometry protocol. Subjects were assigned to supplement with either β-ALA or placebo 
(maltodextrin) in doses of 3.2 g daily for days one through seven and 6.4 g daily for days eight through 
28. Subjects were tested prior to and following supplementation. Results showed that β-ALA 
supplementation increased PWCFT by 12.6%, VT by 13.9%, and time to exhaustion by 2.5%.  
Stout and colleagues [61] also recently examined the effects of three months of β-ALA 
supplementation on PWCFT in elderly men and women. Participants supplemented with either 2.4 g β-
ALA or placebo (microcrystalline cellulose) three times per day for the duration of the study. Results 
revealed that β-ALA supplementation increased physical working capacity in an elderly population by 
28.5%. The researchers attributed these findings to an increase in muscle carnosine concentrations 
leading to an enhanced buffering capacity, although carnosine was not directly measured in this  
study [61]. The data related to by β-ALA and muscular fatigue show promise for improvements with 
supplementation, but still requires future research.  
 
3.5. Beta-Alanine and Creatine Supplementation  
 
Approximately 95% of the total creatine found in the body is located in skeletal muscles, of which 
40% is free creatine and 60% is phosphorylated creatine [72]. Creatine has several roles in the body 
during exercise, with one of the most important being as an energy source for high-intensity exercise 
bouts. Performances that require immediate energy (such as maximal sprints) utilize high energy 
phosphate, ATP and PCr that are stored in the muscles. The reversible reaction in which this energy is 
released is: PCr + ATP Å creatine kinase Æ ATP + creatine [73]. Creatine supplementation enhances 
the initial stores and availability of PCr and therefore, theoretically would enhance the mechanisms of 
the phosphagen system used in high-intensity exercise and improve the shuttling of high-energy 
phosphates in the creatine phosphate shuttle that may potentially improve anaerobic and aerobic 
capacity [74,75]. 
During short-duration high-intensity exercise, ATP is rapidly consumed to provide energy for the 
given activity. In order to continue at the same intensity, the body must quickly resynthesize ATP from 
its byproducts. At maximal intensities, this is primarily achieved by anaerobic degradation of PCr and 
glycogen. The main function of PCr breakdown in this case is to act as an initial buffer and delay the 
reliance on glycogenolysis [66]. The decrease in maximal force production has been linked to PCr 
stores in a direct relationship [76]. Creatine supplementation in doses of 20–30 g/day have shown to 
increase skeletal creatine content by about 20%, where 20–30% of this is as PCr [77]. Creatine 
supplementation also shows to speed the PCr resynthesis within the first minute of recovery from 
intense muscular activity [78]. 
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Creatine supplementation has been extensively studied and is known to have ergogenic properties in 
power and strength athletes, with recent studies showing supplementation resulting in increases in 
muscular strength, anaerobic power, and body mass [66,79-81]. In fact, the majority of long term 
training studies with creatine suggests an ergogenic effect with supplementation in a variety of 
populations including trained adolescents, adults and the elderly [11]. For example, Kreider and 
colleagues [82] examined the effects of 28 days of creatine supplementation during training for college 
football players. Subjects supplemented their diet with either a carbohydrate electrolyte placebo or this 
same supplement containing 15.75 g/day creatine monohydrate for 28 days while engaged in 
resistance-training and agility exercises. The researchers reported that the group supplementing with 
creatine had greater gains in fat free mass, bench press lifting volume, and repetitive sprint 
performance on a cycle ergometer compared to the placebo [82]. More recently, studies have examined 
the effects of supplementing the diet with creatine monohydrate and β-ALA on exercise performance 
and training adaptations.  
A study by Hoffman and colleagues [12] used male power athletes and supplemented their diet with 
creatine or a combination of β-ALA and creatine. The supplementation doses were 10.5 g daily of 
creatine monohydrate; 10.5 g daily of creatine monohydrate in combination with 3.2 g daily of β-ALA; 
or, 10.5 g daily of dextrose as a placebo. In addition to supplementation, subjects were involved in a 
ten week detailed resistance training program with workouts four days a week. The researchers 
reported significant improvements in body composition after ten weeks of the combined 
supplementation of β-ALA and creatine in conjunction with resistance training compared to creatine 
alone or placebo. Additionally, they showed the addition of β-ALA to creatine was able to reduce 
fatigue rates during training compared to creatine alone. These findings suggest that there may be 
additive effects of supplementation of creatine and β-ALA.  
Stout and coworkers [4] examined the effects of 28 days of β-ALA and creatine supplementation on 
neuromuscular fatigue and PWCFT. In the study, 51 men supplemented their diet with either 34 g of a 
dextrose placebo; 5.25 g of creatine with 34 g of dextrose; 1.6 g of β-ALA with 34 g of dextrose; or, 
1.6 g of β-ALA with 5.25 g of creatine and 34 g of dextrose. Subjects ingested this dose four times a 
day for the first six days, and then only twice a day for the remainder of the study. Results revealed 
that PWCFT increased in the β-ALA group with no additive effect of creatine. The researchers 
suggested that 28 days of β-ALA supplementation was able to delay neuromuscular fatigue during 
incremental cycling but this was independent of the inclusion of creatine [4]. 
A study by Zoeller and associates [10] examined the effects of four weeks of creatine and β-ALA 
supplementation on VO2peak, lactate threshold (LT), VT and TTE. This study had four 
supplementation groups including a placebo of 34 g dextrose; 5.25 g creatine monohydrate plus 34 g 
dextrose; 1.6 g β-ALA plus 34 g dextrose; and, a combination of 5.25 g creatine monohydrate and 1.6 
g β-ALA plus 34 g dextrose. Subjects ingested these supplements four times a day for six days and 
then twice a day for the duration of the study. The combined creatine and β-ALA supplementation 
resulted in significant increases in five of the eight cardiorespiratory endurance variables tested (VO2 
and power output at LT and VT, and percent VO2 peak at VT). Individually, results revealed 
improvements in power output at VT and total TTE for creatine alone group and improvements in 
power output at LT for β-ALA alone group. However, no significant effects were noted between 
groups. Therefore, it was concluded that the combination of creatine and β-ALA supplementation may 
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potentially be beneficial in improving submaximal exercise performance when measured at the lactate 
and ventilatory thresholds [10]. Collectively, these findings suggest that there may be benefit of 
supplementing the diet with creatine and β-ALA but it is unclear whether these benefits are 
independent or additive in nature.  
 
3.6. Summary of Beta-Alanine Supplementation  
 
The use of β-ALA in recent research has shown to increase muscle carnosine concentrations in as 
short as two weeks, with increasing levels with longer supplementation periods [6,55]. However, 
although there is strong support that β-ALA supplementation during training possesses ergogenic 
value, the specific mechanism of action and ergogenic value remains to be fully examined. Some 
studies show that β-ALA supplementation can improve high intensity exercise capacity, delay VT 
and/or neuromuscular fatigue, promoted greater gains in lean body mass during training, and increase 
VO2peak or time to exhaustion. On the other hand, other studies show limited effects of β-ALA 
supplementation on exercise performance. The combination of β-ALA and creatine monohydrate 
supplementation is still a new field of research with conflicting results. Additive effects were shown in 
one study for improving fatigue rates with a resistance training program as well as for increasing lean 
body mass [12]. Combined supplementation was also shown to improve VT and LT during 
incremental cycle exercise [10]. Other studies failed to show additive effects for variables such as 
anaerobic power [12] and PWCFT [4]. However, dosing patterns differed in these studies so it is 
difficult to draw definitive conclusions.  
 
4. Future Directions 
 
Future research is needed to examine the effects of β-ALA supplementation on muscle carnosine 
concentrations as well as the physiological effects of increasing muscle carnosine. In this regard, more 
research should be conducted to understand the effects of β-ALA supplementation and corresponding 
increases in muscle carnosine concentrations on muscle buffering capacity, antioxidant properties, 
enzyme regulation, calcium regulation, exercise capacity, performance outcomes, and neuromuscular 
fatigue. An important direction for future research is the determination of an optimal dosing strategy of 
β-ALA in order to optimize increases in muscle carnosine concentrations, physiological adaptations, 
and performance. The current literature shows many variations in the amount and length of β-ALA 
supplementation; therefore, a standard strategy is still pending. Studies should also examine whether 
different types of exercise training may influence muscle carnosine to a greater degree in order to 
determine the most effective method of raising carnosine levels. Determining the correct combination 
of training and supplementation dose may be especially important in the athletic populations. It will 
also be important to study the long-term safety and efficacy of β-ALA supplementation.  
Further research is clearly warranted to assess the efficacy of β-ALA and other ergogenic nutrients 
such as creatine. Creatine loading significantly increases muscle phosphagen levels within a few days 
whereas it has been determined that β-ALA supplementation takes several weeks to increase muscle 
carnosine concentrations. Therefore, future research should examine effective dosing strategies to 
optimize the benefits of both supplements. It is also possible that different types of athletes may benefit 
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from both β-ALA and creatine supplementation. Therefore, studies need to be conducted to examine 
the potential ergogenic value in trained athletes with supplementation. In addition, studies examining 
the effects on exercise recovery may be useful since β-ALA and creatine supplementation has been 
reported to delay fatigue. The majority of current research has focused on the effects in young men, 
with the exception of the studies by Stout and associates [8,61] which examined the effects in women 
and the elderly. Nevertheless, additional research is needed to examine whether age and/or gender may 
influence results. Another area that should be investigated is supplementing the diet with β-ALA may 
provide some therapeutic benefit for patients with various neuromuscular and/or muscle wasting 
diseases as has been reported with creatine supplementation. Finally, additional research should 
examine the possible synergistic effects of β-ALA with other nutrients.  
 
5. Conclusion 
 
β-ALA supplementation is a relatively recent and growing area of research. It carries potential 
beneficial effects with high-intensity exercise including anaerobic sprints and resistance training. 
There is also potential for additive effects of β-ALA and creatine, along with other supplements, to 
further enhance the possible ergogenic effects. There are many possibilities for future research 
opportunities regarding the use of this supplement. The future of β-ALA may potentially open the door 
to further improvements in high-intensity exercise and sport performance in a wide range  
of individuals.  
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